Special edition

In this deep dive, BioSpace examines what’s next for Leqembi, the true cost of anti-amyloid antibodies, and what other Alzheimer’s treatments are coming down the pipeline.

If it feels like there has never been a tougher time to look for work, you’re not alone—and you’re likely not wrong.

In this deep dive, BioSpace examines how small, medium and large companies are using artificial intelligence and machine learning to enhance their drug discovery efforts.

In this job market report we’re reviewing life sciences job market movement in Q3 and what to expect for Q4 and beyond.

In this special report, BioSpace examines how the biopharma industry is grappling with impending consequences of the Inflation Reduction Act.